- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sedation-related Complications in Japan
Total 1125 results
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
Bristol-Myers SquibbCompletedAdvanced Pancreatic CancerUnited States, Canada, Germany, United Kingdom, Taiwan, Italy, Korea, Republic of, Switzerland, Denmark, Japan, Spain
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark, France, Germany, Japan, Sweden, United Kingdom
-
Translational Research Center for Medical Innovation...CompletedAnaplastic Thyroid CancerJapan
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR)RecruitingSarcoidosis | Cardiac SarcoidosisUnited States, Canada, United Kingdom, Japan
-
TakedaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
AstraZenecaActive, not recruiting
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
Novartis PharmaceuticalsTerminatedCentral Retinal Vein OcclusionChina, Czechia, Germany, Russian Federation, Turkey, United States, Australia, Canada, Spain, United Kingdom, Thailand, Israel, Netherlands, Italy, Hungary, France, Greece, Puerto Rico, Malaysia, Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
Novo Nordisk A/SRecruitingAlcohol-related Liver DiseaseCzechia, Denmark, Italy, Netherlands, Canada, Spain, United States, Australia, Japan, Greece, France, Poland, Bulgaria, Germany
-
AstraZenecaActive, not recruitingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)Japan
-
TheracosCompletedDiabetes Mellitus, Type 2United States, Japan
-
AbbVieCompletedAdvanced Solid TumorsUnited States, Australia, Austria, Belgium, Canada, Finland, France, Japan, Spain, Taiwan
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 1Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
-
SunovionCompletedBipolar DepressionUnited States, Canada, Colombia, Czech Republic, India, Japan, Lithuania, Peru, Slovakia, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Merck Sharp & Dohme LLCActive, not recruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian CancerUnited States, Germany, Israel, Canada, China, Australia, Belgium, Brazil, Chile, Colombia, Denmark, Finland, France, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Russian Federation, Turkey and more
-
Prof. Valérie Mc LinEuropean Society of Pediatric Gastroenterology, Hepatology and Nutrition; European... and other collaboratorsEnrolling by invitationCongenital Porto-Systemic Shunt (CPSS)Spain, United Kingdom, Canada, United States, Netherlands, France, Israel, Germany, Australia, Turkey, Switzerland, Japan, Belgium, Greece, Hungary, India, Italy
-
AmgenAmgen Astellas Biopharma K.K.CompletedRelapsed Refractory B Precursor Acute Lymphoblastic LeukemiaJapan
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
-
BayerTerminatedEndometriosisSpain, Belgium, United States, Germany, Austria, Japan, Canada, Hungary, Bulgaria, Italy, China, Czechia, Finland, Norway, Poland, Slovakia, Estonia, Greece, Latvia, Lithuania
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Belgium, Spain, Taiwan, Korea, Republic of, Japan, Italy, Denmark, Israel, Canada, France, India, Netherlands, Germany
-
Mario Negri Institute for Pharmacological ResearchHoffmann-La RocheActive, not recruitingEndometrial CancerNew Zealand, Korea, Republic of, United Kingdom, Italy, Spain, Japan, Germany, Australia, Switzerland, Austria, Taiwan
-
GOG FoundationNational Cancer Institute (NCI)CompletedHydatidiform Mole | Choriocarcinoma | FIGO Stage I Gestational Trophoblastic Tumor | FIGO Stage II Gestational Trophoblastic Tumor | FIGO Stage III Gestational Trophoblastic TumorUnited States, Korea, Republic of, Canada, Japan, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
AbbVieRecruitingAdvanced Solid Tumors CancerUnited States, Australia, Israel, Japan, Korea, Republic of, Puerto Rico, Spain, Taiwan, Canada, France, Belgium
-
Novartis PharmaceuticalsRecruitingIC-MPGNFrance, Germany, Spain, Switzerland, Japan, United States, Canada, India, United Kingdom, Israel, Brazil, Turkey, Italy, Vietnam, Argentina, Czechia, Poland
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)United States, France, Spain, Taiwan, United Kingdom, Australia, Belgium, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Austria, Canada
-
Hoffmann-La RocheRecruitingChildhood Idiopathic Nephrotic SyndromeBelgium, United States, Poland, China, France, Spain, Japan, Brazil, Italy, Turkey
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, Korea, Republic of, China, Japan, India, France, Turkey, Portugal, Spain, Taiwan, Czechia, Sweden, Brazil, Denmark, Singapore, Argentina, Germany, Ireland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, Austria, Japan, Norway, Puerto Rico
-
PfizerTerminatedAchondroplasiaUnited States, Canada, China, Japan, Australia, Germany, France, United Kingdom, Denmark, Belgium, Italy, Portugal, Spain, Switzerland
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
PfizerTerminatedFocal Segmental Glomerulosclerosis (FSGS)United States, Spain, Czechia, Canada, France, Germany, United Kingdom, Poland, Japan, Mexico, Italy, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Centre Hospitalier Universitaire de BesanconEuropean Network of Gynaecological Oncological Trial Groups (ENGOT); ARCAGY...RecruitingCervical CancerSpain, France, Germany, Czechia, Switzerland, China, Japan, Brazil, Italy, Canada, India, Norway, Slovakia
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC; Loxo Oncology, Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Biliary Tract NeoplasmsCanada, United States, Japan, Australia, France, Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Taiho Pharmaceutical Co., Ltd.TTY BiopharmCompletedPancreatic CancerJapan, Taiwan
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain